206 related articles for article (PubMed ID: 23342133)
1. Vav1 fine tunes p53 control of apoptosis versus proliferation in breast cancer.
Sebban S; Farago M; Gashai D; Ilan L; Pikarsky E; Ben-Porath I; Katzav S
PLoS One; 2013; 8(1):e54321. PubMed ID: 23342133
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic Vav1 induces Rac-dependent apoptosis via inhibition of Bcl-2 family proteins and collaborates with p53 deficiency to promote hematopoietic progenitor cell proliferation.
Gu Y; Siefring JE; Wang L; Chae HD; Bailey JR; Zheng Y
Oncogene; 2006 Jun; 25(28):3963-72. PubMed ID: 16474842
[TBL] [Abstract][Full Text] [Related]
3. Estrogen induces Vav1 expression in human breast cancer cells.
Du MJ; Chen XD; Zhou XL; Wan YJ; Lan B; Zhang CZ; Cao Y
PLoS One; 2014; 9(6):e99052. PubMed ID: 24905577
[TBL] [Abstract][Full Text] [Related]
4. The haematopoietic specific signal transducer Vav1 is aberrantly expressed in lung cancer and plays a role in tumourigenesis.
Lazer G; Idelchuk Y; Schapira V; Pikarsky E; Katzav S
J Pathol; 2009 Sep; 219(1):25-34. PubMed ID: 19533802
[TBL] [Abstract][Full Text] [Related]
5. High nuclear level of Vav1 is a positive prognostic factor in early invasive breast tumors: a role in modulating genes related to the efficiency of metastatic process.
Grassilli S; Brugnoli F; Lattanzio R; Rossi C; Perracchio L; Mottolese M; Marchisio M; Palomba M; Nika E; Natali PG; Piantelli M; Capitani S; Bertagnolo V
Oncotarget; 2014 Jun; 5(12):4320-36. PubMed ID: 24962430
[TBL] [Abstract][Full Text] [Related]
6. Vav1 promotes lung cancer growth by instigating tumor-microenvironment cross-talk via growth factor secretion.
Sebban S; Farago M; Rabinovich S; Lazer G; Idelchuck Y; Ilan L; Pikarsky E; Katzav S
Oncotarget; 2014 Oct; 5(19):9214-26. PubMed ID: 25313137
[TBL] [Abstract][Full Text] [Related]
7. Vav1 downmodulates Akt in different breast cancer subtypes: a new promising chance to improve breast cancer outcome.
Grassilli S; Brugnoli F; Lattanzio R; Marchisio M; Perracchio L; Piantelli M; Bavelloni A; Capitani S; Bertagnolo V
Mol Oncol; 2018 Jun; 12(7):1012-1025. PubMed ID: 29658179
[TBL] [Abstract][Full Text] [Related]
8. Vav1: A Dr. Jekyll and Mr. Hyde protein--good for the hematopoietic system, bad for cancer.
Katzav S
Oncotarget; 2015 Oct; 6(30):28731-42. PubMed ID: 26353933
[TBL] [Abstract][Full Text] [Related]
9. Human Vav1 expression in hematopoietic and cancer cell lines is regulated by c-Myb and by CpG methylation.
Ilan L; Katzav S
PLoS One; 2012; 7(1):e29939. PubMed ID: 22253833
[TBL] [Abstract][Full Text] [Related]
10. A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation.
Brekman A; Singh KE; Polotskaia A; Kundu N; Bargonetti J
Breast Cancer Res; 2011 Jan; 13(1):R3. PubMed ID: 21223569
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells.
Butt AJ; Firth SM; King MA; Baxter RC
J Biol Chem; 2000 Dec; 275(50):39174-81. PubMed ID: 10998426
[TBL] [Abstract][Full Text] [Related]
12. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
13. Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation.
Lewis JS; Meeke K; Osipo C; Ross EA; Kidawi N; Li T; Bell E; Chandel NS; Jordan VC
J Natl Cancer Inst; 2005 Dec; 97(23):1746-59. PubMed ID: 16333030
[TBL] [Abstract][Full Text] [Related]
14. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
15. Targeting the Vav1/miR‑29b axis as a potential approach for treating selected molecular subtypes of triple‑negative breast cancer.
Grassilli S; Vezzali F; Cairo S; Brugnoli F; Volinia S; De Mattei M; Judde JG; Bertagnolo V
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33846812
[TBL] [Abstract][Full Text] [Related]
16. VAV1 mutations contribute to development of T-cell neoplasms in mice.
Fukumoto K; Sakata-Yanagimoto M; Fujisawa M; Sakamoto T; Miyoshi H; Suehara Y; Nguyen TB; Suma S; Yanagimoto S; Shiraishi Y; Chiba K; Bouska A; Kataoka K; Ogawa S; Iqbal J; Ohshima K; Chiba S
Blood; 2020 Dec; 136(26):3018-3032. PubMed ID: 32992343
[TBL] [Abstract][Full Text] [Related]
17. Targeting Pancreatic Cancer Metastasis by Inhibition of Vav1, a Driver of Tumor Cell Invasion.
Razidlo GL; Magnine C; Sletten AC; Hurley RM; Almada LL; Fernandez-Zapico ME; Ji B; McNiven MA
Cancer Res; 2015 Jul; 75(14):2907-15. PubMed ID: 25977335
[TBL] [Abstract][Full Text] [Related]
18. Unraveling the Oncogenic Potential of VAV1 in Human Cancer: Lessons from Mouse Models.
Shalom B; Salaymeh Y; Risling M; Katzav S
Cells; 2023 Apr; 12(9):. PubMed ID: 37174676
[TBL] [Abstract][Full Text] [Related]
19. Tumour suppressive effects of WEE1 gene silencing in breast cancer cells.
Ghiasi N; Habibagahi M; Rosli R; Ghaderi A; Yusoff K; Hosseini A; Abdullah S; Jaberipour M
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6605-11. PubMed ID: 24377575
[TBL] [Abstract][Full Text] [Related]
20. Fenugreek, a naturally occurring edible spice, kills MCF-7 human breast cancer cells via an apoptotic pathway.
Khoja KK; Shaf G; Hasan TN; Syed NA; Al-Khalifa AS; Al-Assaf AH; Alshatwi AA
Asian Pac J Cancer Prev; 2011; 12(12):3299-304. PubMed ID: 22471470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
